Source: Eur Respir J , 49 (4)  1602102; DOI: 10.1183/13993003.02102-2016
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Julie Belliere, Antoine Blancher. QuantiFERON test interpretation in patients receiving immunosuppressive agents: an alert. Eur Respir J , 49 (4)  1602102; DOI: 10.1183/13993003.02102-2016

Member's Comments

No comment yet.

Related content which might interest you: Monitoring the efficacy of anti-TB therapy by using the QuantiFERON-TB Gold In tube test Source: Eur Respir Rev 2008; 17: 74-75 Year: 2008 Monitoring the efficacy of anti-TB therapy by using the QuantiFERON-TB Gold in tube test Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007 Individualized treatment regimens with second line anti-TB drugs (SLD) compared to first line anti-TB drug (FLD) only in new pulmonary TB patients, culture confirmed with full sensibility at drug sensibility test (DST) Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011 Prednisolone treatment does affect the performance of the QuantiFERON in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis Source: Annual Congress 2011 - Tuberculosis in special populations Year: 2011 Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease Year: 2007 The assessment of the efficacy of a standard chemotherapy regimen in the treatment of new sputum-positive tuberculosis (TB) patients Source: Eur Respir J 2001; 18: Suppl. 33, 340s Year: 2001 Effects of corticosteroid treatment on the performance of QuantiFERON Gold In-Tube test in the diagnosis of latent tuberculosis infection Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis Year: 2010 Pre-chemotherapy drug sensitivity test for antitubercular drugs in India – is it essential? Source: Eur Respir J 2005; 26: Suppl. 49, 649s Year: 2005 Impact of drug resistance over sputum conversion in tubercular patients receiving re-treatment regimen Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011 Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients Source: Eur Respir J 2007; 30: 945-950 Year: 2007 Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice Source: Eur Respir J 2009; 33: 812-815 Year: 2009 Treatment out-come in acquired drug resistance tuberculous patients receiving tailored regimen based on sensitivity report Source: Annual Congress 2008 - Outcomes of tuberculosis treatment Year: 2008 Design of tuberculosis treatment regimens for drug-resistant and intolerant patients – patient and clinician perspectives Source: International Congress 2018 – CC4 Tuberculosis Year: 2018 Outcomes for multidrug-resistant tuberculosis patients with and without resistance to fluoroquinolones and second-line injectable drugs: A meta-analysis of individual patient data Source: Annual Congress 2012 - Pros and cons of MDR- and XDR-TB treatment Year: 2012 Comparative analysis of the efficacy of glucocorticosteroids and antimetabolite drugs in treatment of patients with pulmonary sarcoidosis Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues Year: 2019 Clinical efficacy of new anti-TB drug ²tubelon² during complex chemotherapy in patients with first-time diagnosed destuctive pulmonary TB Source: Eur Respir J 2006; 28: Suppl. 50, 8s Year: 2006 Outcome of drug resistant TB in hospital settings-a comparision of individualized treatment based on past history of anti-TB drugs with culture sensitivity guided treatment Source: Eur Respir J 2006; 28: Suppl. 50, 589s Year: 2006 Tuberculosis after a borderline QuantiFERON result during screening before infliximab Source: Eur Respir J, 52 (2) 1800913; 10.1183/13993003.00913-2018 Year: 2018 The diagnosis value of QuantiFERON-TB gold test at patients with active tuberculosis Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis Year: 2009 Evaluation of tuberculin responsiveness and booster effect in HIV negative chronic hemodialysis patients and compare of their results with standard skin anergy test Source: Eur Respir J 2005; 26: Suppl. 49, 417s Year: 2005